ArticleACR open rheumatology2019

Safety and Tolerability of Thrombin Inhibition in Scleroderma-Associated Interstitial Lung Disease.

R M Silver et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.